Trial intelligence / Profile preview

Chlorhexidine formulations for subgingival biofilm control

NCT02656251Phase 3Completed

Sponsor
Universidade Federal do Rio Grande do Sul
Start
Jul 2015
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of chlorhexidine in dental plaque, sponsored by Universidade Federal do Rio Grande do Sul. Primary endpoint: Plaque Free Zone Index at 96 hours. Started Jul 2015; status: completed.

02

Drugs

chlorhexidine
03

Conditions

dental plaque

Beyond the preview

Go deeper on NCT02656251.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02656251.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call